Cargando…

Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis

BACKGROUND: The chemokine C-C motif ligand 11, also known as eotaxin-1, has been identified as a novel mediator of inflammatory bone resorption. However, little is known regarding a potential role for CCL11/Eotaxin-1 in postmenopausal osteoporosis. OBJECTIVE: The scope of this study was to explore t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wen, Huang, Ci-You, Wang, Zhuo-Ping, Xu, Shan-Shan, Qian, Tie-Yong, Chen, Yi-Ding, Wu, Wei-Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534958/ https://www.ncbi.nlm.nih.gov/pubmed/31156346 http://dx.doi.org/10.2478/jomb-2018-0042

Ejemplares similares

Eotaxin-1 (CCL11)
por: Williams, Timothy John
Publicado: (2015)

Involvement of Eotaxins (CCL11, CCL24, CCL26) in Pathogenesis of Osteopenia and Osteoporosis
por: AHMADI, Hadis, et al.
Publicado: (2020)

Eotaxin-2 and eotaxin-3 in malaria exposure and pregnancy
por: Mancebo-Pérez, Cristina, et al.
Publicado: (2022)

Serum Interleukin-6 and CCL11/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis
por: Hofmann, Sigrun Ruth, et al.
Publicado: (2017)

Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders
por: Teixeira, Antonio L., et al.
Publicado: (2018)

A‐kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C‐X‐C motif) ligand 1/chemokine (C‐X‐C motif) ligand 2 in acute myeloid leukemia
por: Hao, Xiaohong, et al.
Publicado: (2019)

C–C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation
por: Kubeczko, Marcin, et al.
Publicado: (2016)

FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis
por: Yang, Weiwei, et al.
Publicado: (2022)

Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis
por: Wakabayashi, Kuninobu, et al.
Publicado: (2021)

Eotaxin-1 and MCP-1 serve as circulating indicators in response to power frequency electromagnetic field exposure in mice
por: Li, Hualiang, et al.
Publicado: (2018)

Investigation of candidate genes and mechanisms underlying postmenopausal osteoporosis using bioinformatics analysis
por: Zhu, Xiaozhong, et al.
Publicado: (2018)

Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network
por: Zhang, Chi, et al.
Publicado: (2019)

Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
por: Liu, Lina, et al.
Publicado: (2018)

Role of eotaxin-1/CCL11 in sepsis-induced myocardial injury in elderly patients
por: Li, Ying, et al.
Publicado: (2020)

Serum IL-17 & eotaxin levels in asthmatic patients with allergic rhinitis
por: Lv, Hong, et al.
Publicado: (2016)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Two C‐C Family Chemokines, Eotaxin and RANTES, Are Novel Independent Plasma Biomarkers for Abdominal Aortic Aneurysm
por: Jones, Gregory T., et al.
Publicado: (2016)

Eotaxin and the attraction of eosinophils to the asthmatic lung
por: Conroy, Dolores M, et al.
Publicado: (2001)

Eotaxin levels in patients with primary dysmenorrhea
por: Gul, Evrim, et al.
Publicado: (2018)

Eotaxins and Their Receptor as Biomarkers of Colorectal Cancer
por: Zajkowska, Monika, et al.
Publicado: (2021)

Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis
por: Andrés-Benito, Pol, et al.
Publicado: (2020)

C-C Motif Chemokine Ligand 5 (CCL5) Promotes Irradiation-Evoked Osteoclastogenesis
por: Wang, Jing, et al.
Publicado: (2023)

Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell‐Derived Chemokine (C‐C Motif) Ligand 2 and Chemokine (C‐X‐C motif) Ligand 1 Contributes to Neointima Formation
por: Yu, Baoqi, et al.
Publicado: (2016)

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
por: Zajkowska, Monika, et al.
Publicado: (2022)

Role of Chemokine (C–X–C Motif) Ligand 10 (CXCL10) in Renal Diseases
por: Gao, Jie, et al.
Publicado: (2020)

Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women
por: Chao, Tai-Hung, et al.
Publicado: (2010)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer
por: Zhuo, Changhua, et al.
Publicado: (2018)

CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders
por: Ivanovska, Mariya, et al.
Publicado: (2020)

Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications
por: Nazarinia, Donya, et al.
Publicado: (2022)

Correlation of Serum Chemokine (C-C Motif) Ligand 21 and Heat Shock Protein 90 with Preeclampsia
por: Yang, Weina, et al.
Publicado: (2022)

Construction of an miRNA-Regulated Pathway Network Reveals Candidate Biomarkers for Postmenopausal Osteoporosis
por: Shao, Min
Publicado: (2017)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019)

Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain
por: Selenica, Maj-Linda B, et al.
Publicado: (2013)

Role of chemokine C-C motif ligand-1 in acute and chronic pulmonary inflammations
por: Kishi, Hiroyuki, et al.
Publicado: (2016)

Diagnostic and prognostic values of C-X-C motif chemokine ligand 3 in patients with colon cancer
por: Ruan, Guo-Tian, et al.
Publicado: (2019)

From Allergy to Cancer—Clinical Usefulness of Eotaxins
por: Zajkowska, Monika, et al.
Publicado: (2021)

Regulation of eotaxin expression in skin allergic diseases
por: Peng, Cheng, et al.
Publicado: (2022)

Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1（CXCL1） and C-X-C Motif Chemokine Ligand 6（CXCL6） in models of early alcoholic liver disease
por: Jiang, Yao, et al.
Publicado: (2022)

Chemokine C‐C motif ligand 21 synergized with programmed death‐ligand 1 blockade restrains tumor growth
por: Chen, Qiangda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_knsrqjbub49konkvfkmm11aqtd